Vasomedical Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vasomedical Inc.

VASO 0.170

-1.4%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Francois H. Gaston who wrote (289)	3/5/1997 5:48:00 AM
From: Francois H. Gaston	of 1605

Comments on coming ACC meeting... I cannot wait for the ACC meeting... we will, certainly, have NO data on the multicenter trial (although my understanding is that they are trying to finish the 120 study patients by end of April 1997). On the other hand, there is always potential for important new findings. For example other benefits of EECP (used by chinese for many other indications than improved coronary perfusion). Particularly, I am still looking for improvements in patients with tinnitus (persistent loud noise in their ears), possibly stroke cases, and possibly even improvement in "lack of feelings" in feet as the Mr. Murphy case report hinted at... The latter finding would be great news if EECP works in some peripheral neuropathies, or vascular insufficiencies in the legs... Let's wait and see... potential is there for NEW finding, rather than continuing confirmation of EECP on cardiac perfusion... then again... there might be NO abstract on EECP presented at the meeting... tough to believe, though, when many EECP centers are working now. FHG

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next